Clinical Trials Browser

Recurrence × Denosumab × Clear all

NCT01624766 2021-02-25

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Recurrence

NCT03415477 2018-01-30

Deno-ABC

Phase 1/2 Completed

Fractures, Spontaneous, Neoplasms, Recurrence, Bone Cysts, Aneurysmal